01 December 2005
IgG subclass antibody response to mycobacterial serine protease at differentstages of pulmonary tuberculosis.
Sonika Gupta, Niraj Shende, Amarjeet Bhatia, Satish Kumar, Bhaskar HarinathMed Sci Monit 2005; 11(12): CR585-588 :: ID: 438856
Abstract
Background: Tuberculosis (TB) is a chronic bacterial infection caused by M. Tuberculosis. Studies of antibody response in TB have focussed mainly on their usefulness as a diagnosticserological tool, with little attention given to analysis of antibodies at the isotype and subclass levelin relation to disease pathogenesis. Hence the present study was done to analyse IgG subclass responseat different stages of tuberculosis, in order to understand the immunological events associated withdisease development. Material/Methods: Sera samples were collected from 104 subjects: 79 tuberculosispatients (fresh, relapse and chronic cases) and 25 healthy normals. IgG subclass antibody response wasanalysed by indirect plate peroxidase ELISA against previously reported mycobacterial serine protease(ES-31) antigen. Results: Fresh cases of tuberculosis showed increased IgG1 and IgG3 antibodies, whilea few cases showed moderately increased IgG2. IgG1 and IgG3 were found to be elevated with increasedbacillary load. Relapse and chronic cases showed increased IgG1 and IgG3, while positivity to IgG2 wasdecreased. Chronic cases showed a moderate increase in IgG4 antibody. Thus IgG1 and IgG3 were predominantin all forms of tuberculosis. Conclusions: The elevated levels of IgG1 and IgG3 antibodies to mycobacterialserine protease in active tuberculosis observed in this study provide an additional marker for diagnosisof tuberculosis. Furthermore, the higher level of these antibodies with high bacillary load patientsand in chronic cases of tuberculosis may provide valuable insight into their possible role in diseaseprogression.
Keywords: Antibody Formation, Antibodies, Bacterial - blood, Biological Markers, Disease Progression, Immunoglobulin G - blood, Mycobacterium tuberculosis - immunology, Serine Endopeptidases - immunology, Tuberculosis, Pulmonary - diagnosis
713 15
Editorial
01 May 2023 : Editorial
Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor TherapyDOI: 10.12659/MSM.940911
Med Sci Monit 2023; 29:e940911
In Press
31 May 2023 : Review article
Prevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical Research
A Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review article
A Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database Analysis
The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952